KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Liveperson (LPSN) Payables (2016 - 2025)

Liveperson (LPSN) has disclosed Payables for 16 consecutive years, with $29.6 million as the latest value for Q4 2025.

  • For Q4 2025, Payables rose 92.31% year-over-year to $29.6 million; the TTM value through Dec 2025 reached $29.6 million, up 92.31%, while the annual FY2025 figure was $29.6 million, 92.31% up from the prior year.
  • Payables hit $29.6 million in Q4 2025 for Liveperson, up from $6.6 million in the prior quarter.
  • Across five years, Payables topped out at $86.3 million in Q3 2023 and bottomed at $2.4 million in Q1 2023.
  • Average Payables over 5 years is $26.0 million, with a median of $15.5 million recorded in 2024.
  • On a YoY basis, Payables climbed as much as 621.03% in 2023 and fell as far as 90.66% in 2023.
  • Liveperson's Payables stood at $16.9 million in 2021, then surged by 49.35% to $25.3 million in 2022, then skyrocketed by 239.68% to $85.9 million in 2023, then plummeted by 82.11% to $15.4 million in 2024, then soared by 92.31% to $29.6 million in 2025.
  • According to Business Quant data, Payables over the past three periods came in at $29.6 million, $6.6 million, and $11.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.